SEPTEMBER 03 2024
Nordic Capital is about to conclude its nine-year ownership of Sunrise Medical, a global leader in developing, designing, manufacturing, and distributing innovative, high-quality assistive mobility devices and services, marking the end of a significant chapter. In the wake of this transition, Sunrise Medical's CEO reflects on the transformative partnership, highlighting the major milestones and how the company has solidified its position as a global leader in assistive mobility solutions.
- Could you elaborate on Sunrise Medical’s growth and expansion during Nordic Capital’s ownership?
During Nordic Capital's ownership, Sunrise Medical achieved several important milestones. Since the acquisition in 2015, our revenue has nearly doubled, growing from c.EUR 360 million to c.EUR 695 million in FY 2023/24. The financial growth reflects our continued expansion across products and geographies. Today, Sunrise Medical has a direct presence in 23 countries, with our products sold in over 130 countries through an extensive network of healthcare dealers, government agencies, and public institutions. Our workforce has grown from 2,000 to over 2,800 worldwide, highlighting our commitment to scaling operations and investing in talent. Several strategic acquisitions have expanded our product portfolio and capabilities, reinforcing our status as a global leader in premium mobility products.
- What do you attribute this success to?
Sunrise Medical's growth can be attributed to a combination of several factors. First and foremost, our commitment to innovation and quality in providing assistive mobility solutions has always been at the core of our success. Nordic Capital's long-term perspective, willingness to invest in innovation, and deep industry expertise have guided us in strategic direction and provided resources, paving the way for our future growth. This support allowed us to expand our product portfolio, enter new markets, and enhance our global footprint. Furthermore, it allowed us to invest in research and development, and thereby ensure we remain at the forefront of technology in our field, particularly in the complex rehab solutions.
- How has Sunrise Medical's approach to innovation developed over the last years?
Together, we have fostered a culture of innovation, which has been the key in Sunrise Medical’s success. It has inspired us to think beyond the immediate needs of the market and focus on the long-term impact of our products on the lives of the end users. This has led to significant advancements in our product offering, such as the introduction of increasingly customisable and technologically advanced mobility solutions. The partnership with Nordic Capital allowed us to push the boundaries of what's possible in assistive technology, ensuring that our products not only meet but exceed the expectations of the users.
- How does Sunrise Medical's mission align with Nordic Capital's values?
Sunrise Medical's mission to improve the lives of people with mobility challenges aligns perfectly with Nordic Capital's responsible ownership and sustainable growth values. Both organisations are committed to positively impacting society, and this shared vision has been a cornerstone of our partnership. Nordic Capital's focus on long-term value creation has resonated deeply with our mission, allowing us to pursue growth opportunities that also contribute to the well-being of the broader community.
- What does the future hold for Sunrise Medical?
As Sunrise Medical transitions to its next phase of growth, we are excited about the opportunities ahead. The strong foundation we have created has positioned us well for continued growth and innovation. We remain dedicated to enhancing the quality of life for individuals with mobility needs and will continue to invest in new technologies and expand to new markets. While Nordic Capital's exit marks the end of an important chapter, the values and strategic direction instilled during their ownership will continue to guide us as we move forward.